Theravance, Inc. (THRX) Reports Q2 Loss of 18c/Share
Tweet
Share
E-mailGet Alerts THRX Hot Sheet
Price: $4.06 --0%
Financial Fact:
Loss from operations: 27.92M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Loss from operations: 27.92M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Theravance, Inc. (NASDAQ: THRX) reported Q2 EPS of ($0.18), may not compare to the analyst estimate of ($0.44). Revenue for the quarter came in at $934 thousand versus the consensus estimate of $4.39 million.
For earnings history and earnings-related data on Theravance, Inc. (THRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is the global equity rally broadening? UBS weighs in
- BofA maintains underperform ratings on six BDC stocks
- ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
